COVID-19: WHO Africa head Moeti stands firm over Madagascar medicine.

PUBLISHED: Thu, 14 May 2020 15:08:19 GMT

Matshidiso Moeti, the regional head for Africa for the World Health Organisation , has stood firm in the face of backlash from the continent over her advice to hold back on using herbal medicine from Madagascar against COVID-19.

Social media was alive with criticism in the days following Moeti’s cautious reaction to this a tonic produced from a plant called Artemesia blended with a collection of herbs grown on the island of Madagascar. Madagascan President Andry Rajoelina has presented it to heads of state at the African Union as a herbal prevention of treatment of COVID-19.

“Africa should believe in herself instead of waiting for approval from a foreign organization to provide a cure for COVID-19,”says one tweet this week despite the fact that South Africa has volunteered to test the elixir.

“We survived diseases with our own traditional remedies for centuries without WHO’s approval. We are Africans, the bush is our pharmacy,” say other tweets, “Rather be killed by an African drug than a western vaccine.”

In her response Moeti was diplomatic, yet firm in her response in WHO’s weekly briefing to Africa’s media. She pointed out that WHO had worked for many years with governments to help them integrate African medicine into their health systems and also supported trials of herbal cures.

“Any medicine that is to be used we advise people to take it through trials . We are in talks with Madagascar to see what we can do,” says Moeti.

“We are not at all discouraging the use of the product, but would like to advise  that is tested so when we celebrate the use of this product in Africa is we would like to do so with some evidence from tests behind it.”   

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.